Skip to content

Monolithic zirconia versus porcelain-fused-to-metal implant-supported fixed partial dentures in the posterior jaw region: a randomized controlled clinical trial

Monolithic zirconia versus porcelain-fused-to-metal implant-supported fixed partial dentures in the posterior jaw region: a randomized controlled clinical trial - Mono ZrO2-bridge

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011039
Enrollment
52
Registered
2016-09-06
Start date
2016-11-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.1

Interventions

Group 1: Three-unit implant-supported bridge with monolithic zirconia reconstruction (LAVA Plus zirconia, bonded to titanium base abutment) Group 2: Three-unit implant-supported bridge with porcelain-

Sponsors

Zentrum für Zahnmedizin, Klinik für Rekonstruktive Zahnmedizin, Universität Zürich
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • need of a three-unit FPD supported by an implant in the premolar region and an implant in the molar region (first premolar-first molar or second premolar-second molar) • presence of at least one antagonist tooth • presence of at least one adjacent tooth • implant position enabling a screw-retained FPD

Exclusion criteria

Exclusion criteria: • smoking > 15 cigarettes / day

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is the rate of ceramic fractures (USPHS criteria) at 1, 3 and 5 years

Secondary

MeasureTime frame
Secondary endpoints will be assessed at each follow-up visit (1, 3 and 5 years). • The marginal bone level will be assessed on a periapical radiograph. • The biological outcomes will be assessed by measuring the pocket depth with a periodontal probe and bleeding on probing. • The crown survival will be assessed by means of standardized USPHS criteria. • The wear rate of the crown and the antagonist will be assessed by means of a silicone impression.

Countries

Switzerland

Contacts

Public ContactGoran I. Benic

Zentrum für Zahnmedizin, Klinik für Rekonstruktive Zahnmedizin, Universität Zürich

goran.benic@zzm.uzh.ch+41 44 634 04 04

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 23, 2026